GT Biopharma (GTBP) had the highest return between 2011 and 2012 by a US stock, returning 525,310,195%.

ASSET	YEARS	% RETURN
GT Biopharma (GTBP)	2011-2012	525,310,195.03%
Color Star Technology (ADD)	2011-2012	70,565,542.63%
QXO (QXO)	2011-2012	4,032,075%
Sequans Communications (SQNS)	2011-2012	2,819,177.11%
Castellum (CTM)	2011-2012	815,117.39%
Nixxy (NIXX)	2011-2012	64,900%
Kartoon Studios (TOON)	2011-2012	55,900%
BioLineRx (BLRX)	2011-2012	24,419.07%
Intellinetics (INLX)	2011-2012	8,066.67%
Par Pacific (PARR)	2011-2012	1,900%
Nova Lifestyle I (NVFY)	2011-2012	1,266.67%
Actinium Pharmaceuticals (ATNM)	2011-2012	1,263.64%
Xpel (XPEL)	2011-2012	1,177.78%
Kazia Therapeutics Ltd ADR (KZIA)	2011-2012	1,078.12%
Natural Health Trend (NHTC)	2011-2012	1,021.97%
Versus Systems Inc. (VS)	2011-2012	940%
Heritage Global (HGBL)	2011-2012	816.67%
Patrick Industries (PATK)	2011-2012	674.14%
Barfresh Food (BRFH)	2011-2012	670%
Where Food Comes From (WFCF)	2011-2012	556.24%
Coda Octopus (CODA)	2011-2012	514.62%
Expedia (EXPE)	2011-2012	512.32%
Mawson Infrastructure (MIGI)	2011-2012	500%
Precision Optics Corporation, Inc Common stock (POCI)	2011-2012	466.67%
Lifevantage (LFVN)	2011-2012	461.52%